Xtandi 40 MG tablet 120S

Ended Awarded

Contract number
SPE2DX25F6XMH
Awardee
Awarding agency
Obligated
$41,696

Award facts

Contract value 100% obligated
$41,695.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $41,695.90 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for 120 units of the prescription drug Xtandi 40 mg tablet. The order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The delivery order has an ultimate completion date of July 3, 2025. This contract award does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DX25F6XMH?

SPE2DX25F6XMH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 2, 2025.

How much is contract SPE2DX25F6XMH worth?

The government has obligated $41,696 on SPE2DX25F6XMH.

Is contract SPE2DX25F6XMH an order under another contract?

Yes. SPE2DX25F6XMH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.

Was contract SPE2DX25F6XMH competed?

The extent of competition for SPE2DX25F6XMH was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award